Hematology Franchise Leader, PHC Oncology and Hematology

アメリカ合衆国, カリフォルニア州, South San Francisco
スイス, バーゼル=シュタット準州, Basel
英国, Welwyn

en de fr es ru tr it pt zh

Roche’s Personalized Healthcare (PHC) strategy aims to transform the treatment of disease and improve patient outcomes.  PHC is building capabilities for data and insight sharing, applying advanced analytics to identify new targets and biomarkers in order to enable disease area teams to accelerate clinical trials and create novel opportunities that will improve R&D productivity.  PHC is developing new methods for characterizing disease states and quantifying disease activity.  We are shaping the internal and external environment to enable value recognition from these insights.

As a key part of the PHC strategy, we are building out our capabilities and embedding them within hematology and solid tumor.  Our program will focus on at-scale multi-dimensional datasets including tissue genomics, digital pathology, as well as longitudinal radiologic imaging data and ctDNA, to develop novel, informative and early surrogate endpoints for efficacy.

In this leadership position, you will play a strategic role in Roche’s PHC transformation, driving Roche to the forefront of Oncology/Hematology meaningful data-at-scale and advanced analytics platform.  You will support the Global Oncology Head, PHC in the development of a fully functioning PHC strategy reimagines both R&D and Personalized Patient Care & Access.  These transformative efforts will require a cross-enterprise mindset which brings together both disease area and PHC strategies, as well as the ability to closely enable collaboration across the Roche organization (REDs, Pharma, DIA, Flatiron Health, Foundation Medicine, and other strategic partnerships). 

Key Accountabilities:

Hematology Franchise Leader, PHC Oncology and Hematology will be responsible for:

  • Leading and managing a global cross-functional team responsible for the design and execution of a core strategy, within the overall Onc/Heme PHC program

  • Driving the development of an industry-leading Oncology program focusing on data-at-scale and advanced analytics platforms.  This will include developing the strategy to leverage our internal and external assets, generating high-dimensionality, high quality patient datasets in the real-world setting.

  • Driving development and delivery of the program strategy, fully aligned with and integrated into disease areas, CIT, and overall PHC strategies across R&D.   The program objectives will target the development of data and analytics capabilities, and the overall PHC platform (leveraging across and within Hematology and Oncology).

  • Leading and fostering cross-enterprise internal collaboration essential to successful execution, including partnerships across Pharma, gRED, pRED, IT, Partnering, Dia, Flatiron Health, Foundation Medicine, as well as key governance committees such as CITC, LSPC, RRC.

  • Developing and expanding key external strategic relationships with industry partners, public/private healthcare systems, patient advocacy, cooperative groups, payors, and other stakeholders in the PHC ecosystem, as needed to execute upon the showcase strategy.

  • Ensuring coordination and alignment of key PHC capability development activities, which may include EDIS, Technology/IT platform development, data science in imaging, digital pathology, and omics, and advanced analytics and embedding within the disease areas.

  • Maintain responsibility for budget, resourcing, key milestones, financial targets, and other metrics to measure results.

  • Monitoring the external environment, trends, and other factors which may impact the future direction of the Oncology and Hematology PHC strategy.

  • Aligning, motivating and inspiring others to work in accordance with a cross-enterprise, highly collaborative mindset, as well as mentoring and developing the next generation of PHC leaders.

    Key Qualifications

  • MD, Oncology required.

  • Experienced leader (8+ years pharmaceutical or diagnostics industry) with a record of accomplishment in strategy development, drug development, people leadership, and project execution with large, complex, cross-functional (cross-enterprise) programs/initiatives.

  • Knowledge of Roche Oncology pharma business from discovery research to late stage.  Experience with CIT and core oncology disease areas is preferred.

  • Strong familiarity with data science, including genomics, imaging data, digital pathology

  • Science degree required.

  • Critical thinker with the ability to analyze possibilities and solutions and make pragmatic trade-offs, as well as a “big picture” innovator who can recognize possibilities and lead creative organizations.

    Key Attributes

  • Demonstrated leadership in providing a strategic vision.

  • Proven ability to innovate and derive actionable insights from complex data.

  • Highly effective teamwork and collaboration skills that enable business results through building relationship with others both internally and externally. 

  • Understanding and alignment with organizational objectives and resources to accomplish strategic objectives and financial results.

  • Demonstrates energy, passion, courage, vision and the drive to be at the forefront of a changing and competitive environment for the benefit of patients, our people and the business.

  • Demonstrates competence in thinking strategically, analytically and innovatively.  Able to quickly and creatively analyze and provide solutions to complex challenges.

  • Commitment to developing people and promoting a culture of trust and support.

  • Influencing skills that demonstrate strong thought partnership and create effective relationships with internal and external stakeholders

  • English language fluency both written and oral

  • Ability to travel up to 25%